PetMed Express, inc (NASDAQ:PETS)
Q2 2021 Earnings Call
Oct 25, 2021, 4:30 p.m. ET
- Prepared Remarks
- Questions and Answers
- Call Participants
Welcome to the PetMed’s Conference Call to review the Financial Results for the Second Fiscal Quarter ended on September 30, 2021. [Operator Instructions]
Founded in 1996 PetMeds is become America’s most trusted pet pharmacy delivering prescription and non-prescription pet medications and other health products for the dogs, cats and horses direct to the customer. PetMed’s markets its products through national advertising campaigns with direct customers to order by phone or on the Internet to increase the recognition of the PetMed’s branding. PetMed’s provides an attractive alternative for obtaining pet medications in terms of convenience, price and ease of ordering and rapid home delivery.
At this time, I would like to turn the call over to the Company’s Chief Financial Officer, Mr. Bruce Rosenbloom.
Bruce S. Rosenbloom — Chief Financial Officer
I would like to welcome everybody here today. I would like to remind everyone that the first portion of this conference call will be listen only until the question-and-answer session, which will be later in the call. Also, certain information that will be included in this press conference may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by these statements.
We have identified various risk factors associated with our operations in our most recent Annual Report and other filings with the Securities and Exchange Commission. Let me now introduce our newly appointed CEO and President, Matt Hulett. Matt?
Matt Hulett — President and Chief Executive Officer
Thanks, Bruce. Good morning and thank you for joining us. My name is Matt Hulett, I’m the new CEO PetMed. I’m incredibly honored and enthusiastic to join this …….